Eosinophilic Gastroenteritis Clinical Trial
Official title:
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled 3-Part Phase 3 Study to Demonstrate the Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
This is a 3-part study. Part A is randomized, double-blinded, placebo-controlled and includes patients with eosinophilic gastritis and/or duodenal-only disease. After completing Part A, participants can continue to Part C - open-label benralizumab treatment period. Following the decision to close enrollment, patients in both Part A and Part C will be given the option to proceed to 6-months of open-label benralizumab treatment in Part D.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03320369 -
Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis
|
N/A | |
Completed |
NCT00148603 -
Montelukast in the Treatment of Duodenal Eosinophilia
|
N/A | |
Completed |
NCT03664960 -
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
|
Phase 2 | |
Completed |
NCT00267475 -
Data Bank for Eosinophilic Disorders
|
N/A | |
Completed |
NCT04856891 -
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis
|
Phase 3 | |
Active, not recruiting |
NCT03678545 -
Dupilumab in Eosinophilic Gastritis
|
Phase 2 | |
Terminated |
NCT01814059 -
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
|
Phase 1 | |
Active, not recruiting |
NCT05214768 -
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
|
Phase 3 | |
Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
Completed |
NCT03496571 -
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
|
Phase 2 | |
Recruiting |
NCT02523118 -
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
|
||
Completed |
NCT05439772 -
Examining the Effect of Ondansetron on Bowel Prep Success
|
Phase 4 | |
Completed |
NCT00266565 -
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT05199532 -
Eosinophilic Gastrointestinal Disorders Registry
|
||
Terminated |
NCT01212016 -
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
|
N/A | |
Completed |
NCT02897271 -
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
|